The Chemours Company (CC) belonging to the Basic Materials sector has declined -4.34% and closed its last trading session at $37.03.
Currently, the stock has a 1 Year Price Target of $47.14.
The consensus recommendation, according to Zacks Investment research, is 1.8. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 1.67 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2 and 2.33 respectively.
The Chemours Company reported its EPS as $0.27 with the analysts projecting the EPS of the stock as $0.17. The company beat the analyst EPS Estimate with the difference of $0.1. This shows a surprise factor of 0.588%.
Many analysts have provided their estimated foresights on The Chemours Company Earnings, with 7 analysts believing the company would generate an Average Estimate of $0.82.
Whereas they predicted High and Low Earnings Estimate as $0.89 and $0.75 respectively. While in the same Quarter Previous year, the Actual EPS was $0.27.
Analysts are also projecting an Average Revenue Estimate for The Chemours Company as $1.48 Million in the Current Quarter. This estimate is provided by 4 analysts.
The High Revenue estimate is predicted as 1.49 Million, while the Low Revenue Estimate prediction stands at 1.48 Million. The company’s last year sales total was 1.38 Million.
For the Current Quarter, the growth estimate for The Chemours Company is 203.7%, while for the Next Quarter the stock growth estimate is 52.5%.
Insider Trades for The Chemours Company show that the latest trade was made on 4 Jun 2017 where Kirsch (Paul C), the Officer completed a transaction type “Sell” in which 19036 shares were traded at a price of $41.42.
The Chemours Company (CC) has the market capitalization of $6.71 Billion. The company rocked its 52-Week High of $46.02 and touched its 52-Week Low of $5.82.
The stock has Return on Assets (ROA) of 1.7 percent. Return on Equity (ROE) stands at 42.6% and Return on Investment (ROI) of -1.5 percent.
The stock is currently showing YTD performance of 67.63 Percent. The company has Beta Value of 0 and ATR value of 2.05. The Weekly and Monthly Volatility stands at 6.95% and 4.87%.